Marya Lieberman
Chemistry and Biochemistry
Professor of Chemistry
- Low-quality medicines
- Fake pharmaceuticals
- Counterfeit drug detection
- Fentanyl (opioid) detection
Lieberman’s 91视频
Lieberman in the News
Newsweek
February 15, 2025
Marya Lieberman, an analytical chemist at the University of Notre Dame who specializes in the detection of substandard and falsified pharmaceuticals, said regulators face a daunting task to remove these illicit sites. "To protect patients, DEA and FDA try to identify fake pharmacy sites and shut them down, but it's like playing Whac-A-Mole—as soon as they take one site down, another one pops up," she told Newsweek.
South Bend Tribune
August 09, 2024
The forum will feature the following panelists: Marya Lieberman is an analytical chemist and professor in the Department of Chemistry and Biochemistry at the University of Notre Dame. She is a member of Notre Dame Lead Innovation Team.
South Bend Tribune
June 27, 2024
Ornella Joseph and Vikrant Jandev, graduate students with the Notre Dame Lead Innovation Team, provided lead testing at the summer kickoff at Randolph Park on June 1.
WTHR (Indianapolis)
Video
June 06, 2024
Researchers at University of Notre Dame test fentanyl and other test strips for their effectiveness. Dr. Marya Lieberman’s team tested five different test strip brands on more than 200 compounds. Lieberman found that while there are sometimes false positives, overwhelmingly, the strips on the market are accurate and effective when used properly.
Bloomberg
Video
December 14, 2023
Marya Lieberman is a chemistry professor at the University of Notre Dame. She has blue hair, a refrigerator full of chemo drugs and obvious enthusiasm for the intricacies of lab testing. Over the years she’d heard about issues with the quality of chemo drugs in low-income countries.
October 06, 2023
Now, researchers led by Professor Marya Lieberman of the University of Notre Dame have made the drug a focus of their work developing devices that flag poor-quality medicines.
Bloomberg
January 27, 2021
Marya Lieberman, a professor in the department of chemistry and biochemistry at the University of Notre Dame in Indiana, agreed that safety concerns would likely be a deal killer.